Agf Investments Inc. Dexcom Inc Transaction History

Agf Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $50,132 - $66,808	-619 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $1,271 - $1,571	-15 Reduced 2.37%	619 $222,000
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $48,906 - $65,521	627 Added 8957.14%	634 $234,000
Q2 2020 Aug 11, 2020	SELL	$62.68 - $105.34 $63,306 - $106,393	-1,010 Reduced 99.31%	7 $3,000
Q1 2020 May 08, 2020	BUY	$47.79 - $75.63 $48,602 - $76,915	1,017 New	1,017 $274,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.